Rest Ez INC. (RTEZ) — SEC Filings
Latest SEC filings for Rest Ez INC.. Recent 10-Q filing on Dec 23, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.
View Rest Ez INC. on SEC EDGAR
Overview
Rest Ez INC. (RTEZ) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Dec 23, 2025: REST EZ Inc. reported no revenue for the three months ended June 30, 2025, consistent with the prior year period. The company also recorded a net loss of $0 for the quarter, a significant improvement from the net loss of $33 in the same period of 2024. Total assets and total stockholders' equity rem
Sentiment Summary
Across 8 filings, the sentiment breakdown is: 2 bearish, 6 neutral. The dominant filing sentiment for Rest Ez INC. is neutral.
Filing Type Overview
Rest Ez INC. (RTEZ) has filed 4 10-Q, 2 10-K, 2 8-K with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent Filings (8)
-
REST EZ Reports Zero Revenue, $0 Net Loss Amid Going Concern Doubts
— 10-Q · Dec 23, 2025 Risk: high
REST EZ Inc. reported no revenue for the three months ended June 30, 2025, consistent with the prior year period. The company also recorded a net loss of $0 for -
REST EZ Faces Steep Competition, Single-Customer Reliance
— 10-K · Dec 16, 2025 Risk: high
REST EZ Inc. (RTEZ) reported for the fiscal year ended March 31, 2025, that it has commenced nationwide distribution of its Rest EZ Sleep Aid Supplement soft ge -
REST EZ Inc. Files 8-K Under 'Other Events'
— 8-K · Jul 10, 2025 Risk: low
REST EZ, Inc. filed an 8-K on July 10, 2025, reporting an event that occurred on July 2, 2025. The filing is categorized under 'Other Events' and does not speci -
REST EZ Inc. Files 8-K for Other Events
— 8-K · Jul 9, 2025 Risk: low
REST EZ Inc. filed an 8-K on July 9, 2025, reporting an event that occurred on July 2, 2025. The filing pertains to 'Other Events' and provides updated contact -
REST EZ Inc. Files Q2 2024 10-Q Report
— 10-Q · Apr 25, 2025 Risk: low
REST EZ, Inc. filed its 10-Q report for the quarter ended June 30, 2024. The company, incorporated in Wyoming and headquartered in Riverton, UT, operates in the -
REST EZ, Inc. Files 2024 Annual Report
— 10-K · Feb 13, 2025 Risk: low
REST EZ, Inc. filed its annual report on Form 10-K for the fiscal year ended March 31, 2024. The company, incorporated in Wyoming and headquartered in Riverton, -
REST EZ Inc. Files Quarterly Report (10-Q) for Period Ended December 31, 2023
— 10-Q · Mar 7, 2024 Risk: low
REST EZ Inc. (RTEZ) filed a Quarterly Report (10-Q) with the SEC on March 7, 2024. REST EZ Inc. filed a Form 10-Q for the quarterly period ended December 31, 20 -
REST EZ Inc. Files Quarterly Report for Period Ending September 30, 2023
— 10-Q · Jan 16, 2024 Risk: low
REST EZ Inc. (RTEZ) filed a Quarterly Report (10-Q) with the SEC on January 16, 2024. REST EZ Inc. filed a Form 10-Q for the quarter ended September 30, 2023. T
Risk Profile
Risk Assessment: Of RTEZ's 8 recent filings, 2 were flagged as high-risk, 0 as medium-risk, and 6 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
Key financial metrics from Rest Ez INC.'s most recent 10-Q filing (Dec 23, 2025):
- Revenue: $0
- Net Income: $0
- EPS: $0.00
- Debt-to-Equity: N/A
- Cash Position: $300
- Operating Margin: N/A
- Total Assets: $300
- Total Debt: $0
Key Executives
- Brandon Sosa
- Mr. Carson
- Dylan Carson
- 8 years
Industry Context
The sleep aid supplement market is competitive, with numerous established brands and emerging players. Key trends include a growing consumer interest in natural and non-habit-forming sleep solutions, and increasing online sales channels. However, regulatory scrutiny and efficacy claims are critical factors for success.
Top Tags
10-Q (3) · Microcap (2) · High Risk (2) · REST EZ Inc. (2) · Quarterly Report (2) · Financial Statements (2) · SEC Filing (2) · Going Concern (1) · Zero Revenue (1) · Sleep Aid Supplement (1)
Key Numbers
- Revenue: $0 — for the three months ended June 30, 2025, unchanged from 2024
- Net Loss: $0 — for the three months ended June 30, 2025, improved from $33 loss in 2024
- Total Assets: $300 — as of June 30, 2025, unchanged from March 31, 2025
- Cash: $300 — as of June 30, 2025, unchanged from March 31, 2025
- Accumulated Deficit: $286,101 — as of June 30, 2025, indicating significant historical losses
- Shares Outstanding: 27,537,033 — as of June 30, 2025, increased from 20,000,000 in 2024
- Working Capital Deficit: $3,018 — As of March 31, 2025, indicating insufficient capital for 12 months of operations.
- Aggregate Market Value of Non-Affiliate Common Stock: $80,000 — As of March 31, 2025.
- Major Customer: 1 — Source of all product sales and revenue, creating high concentration risk.
- CEO's Weekly Devotion: 28 hours — Dylan Carson's current time commitment to the company without salary.
- Planned CEO Monthly Salary: $2,000 — Dylan Carson's salary once the company achieves self-sufficiency.
- Period End Date: 20231231 — Quarterly report period
- Filing Date: 20240307 — Date the report was filed
- Outstanding Shares: 27,537,033 — As of February 20, 2024
- SIC Code: 2834 — Pharmaceutical Preparations
Frequently Asked Questions
What are the latest SEC filings for Rest Ez INC. (RTEZ)?
Rest Ez INC. has 8 recent SEC filings from Jan 2024 to Dec 2025, including 4 10-Q, 2 10-K, 2 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of RTEZ filings?
Across 8 filings, the sentiment breakdown is: 2 bearish, 6 neutral. The dominant sentiment is neutral.
Where can I find Rest Ez INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Rest Ez INC. (RTEZ) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Rest Ez INC.?
Key financial highlights from Rest Ez INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for RTEZ?
The investment thesis for RTEZ includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Rest Ez INC.?
Key executives identified across Rest Ez INC.'s filings include Brandon Sosa, Mr. Carson, Dylan Carson, 8 years.
What are the main risk factors for Rest Ez INC. stock?
Of RTEZ's 8 assessed filings, 2 were flagged high-risk, 0 medium-risk, and 6 low-risk.
What are recent predictions and forward guidance from Rest Ez INC.?
Forward guidance and predictions for Rest Ez INC. are extracted from SEC filings as they are enriched.